Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: VALGANCICLOVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic valganciclovir product, authorizing Camber Pharmaceuticals to market valganciclovir for the established CM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir (Valganciclovir)

Snippet

SUPPL AP for VALGANCICLOVIR (VALGANCICLOVIR)